Literature DB >> 3677988

Hypercortisolism in diabetes mellitus.

O G Cameron, B Thomas, D Tiongco, M Hariharan, J F Greden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3677988     DOI： 10.2337/diacare.10.5.662

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  12 in total

1.  Associations of salivary cortisol levels with metabolic syndrome and its components: the multi-ethnic study of atherosclerosis.

Authors:  A S DeSantis; A V DiezRoux; A Hajat; S H Golden; N S Jenny; B N Sanchez; S Shea; T E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

2.  Glucocorticoid dynamics and impaired wound healing in diabetes mellitus.

Authors:  M S Bitar
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 3.  Glucose metabolism in patients with subclinical Cushing's syndrome.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Elisa Marinazzo; Andreea Picu; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-03-06       Impact factor: 3.633

Review 4.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

5.  The longitudinal association of changes in diurnal cortisol features with fasting glucose: MESA.

Authors:  Jenny Pena Dias; Joshua J Joseph; Bjorn Kluwe; Songzhu Zhao; Michelle Shardell; Teresa Seeman; Belinda L Needham; Gary S Wand; David Kline; Guy Brock; Cecilia Castro-Diehl; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2020-07-13       Impact factor: 4.905

6.  Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Authors:  Rebecca M Reynolds; Javier Labad; Mark W J Strachan; Anke Braun; F Gerry R Fowkes; Amanda J Lee; Brian M Frier; Jonathan R Seckl; Brian R Walker; Jackie F Price
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

Review 7.  Cognitive function, dementia and type 2 diabetes mellitus in the elderly.

Authors:  Mark W J Strachan; Rebecca M Reynolds; Riccardo E Marioni; Jacqueline F Price
Journal:  Nat Rev Endocrinol       Date:  2011-02       Impact factor: 43.330

8.  A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice.

Authors:  Qian Wang; Tingqing Guo; Jennifer Portas; Alexandra C McPherron
Journal:  Int J Biol Sci       Date:  2015-01-05       Impact factor: 6.580

9.  Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Authors:  Rebecca M Reynolds; Mark W J Strachan; Javier Labad; Amanda J Lee; Brian M Frier; F Gerald Fowkes; Rory Mitchell; Jonathan R Seckl; Ian J Deary; Brian R Walker; Jackie F Price
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

10.  Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study.

Authors:  Luiz Augusto Casulari; Donatella Dondi; Fabio Celotti; Fábio Vinicius Pires da Silva; Caio Eduardo Gonçalves Reis; Teresa Helena Macedo da Costa
Journal:  Diabetol Metab Syndr       Date:  2015-07-22       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.